基于膝关节X射线的人工智能驱动病理检测与骨关节炎分级多中心研究
A Multi-Site Study on AI-Driven Pathology Detection and Osteoarthritis Grading from Knee X-Ray
AI总结：
本研究提出一种AI系统，利用130万张多中心膝关节X射线检测病理并分级骨关节炎，通过ResNet15和DenseNet等模型实现高精度诊断，验证了其泛化能力，为资源有限环境提供可扩展的骨骼健康解决方案。
摘要：
引言：骨关节炎和骨质疏松等骨骼健康疾病构成重大全球健康挑战，常因诊断工具有限而导致诊断延迟。本研究提出一种人工智能系统，用于分析膝关节X射线，检测关键病理特征，包括关节间隙狭窄、硬化、骨赘、胫骨骨刺、力线问题和软组织异常。该系统还对骨关节炎严重程度进行分级，从而实现及时、个性化的治疗。\n研究设计：研究使用了来自印度多中心临床试验的130万张膝关节X射线，涵盖政府医院、私立医院和中小型医院。数据集确保了人口统计学、影像设备和临床环境的多样性。严格的标注和预处理生成了高质量的训练数据集，用于病理特异性模型，如用于关节间隙狭窄的ResNet15和用于骨关节炎分级的DenseNet。\n性能：该AI系统在多样化的影像环境中实现了强大的诊断准确性。病理特异性模型在精确率、召回率和阴性预测值方面表现出色，并通过均方误差（MSE）、交并比（IoU）和Dice系数进行了验证。按年龄、性别和设备制造商进行的亚组分析证实了其在真实世界应用中的泛化能力。\n结论：这一可扩展、经济高效的骨骼健康诊断解决方案在多中心试验中表现出稳健性能。它有望在资源有限的医疗环境中得到广泛应用，从而变革骨骼健康管理并实现主动的患者护理。
英文摘要：
Introduction: Bone health disorders like osteoarthritis and osteoporosis pose major global health challenges, often leading to delayed diagnoses due to limited diagnostic tools. This study presents an AI-powered system that analyzes knee X-rays to detect key pathologies, including joint space narrowing, sclerosis, osteophytes, tibial spikes, alignment issues, and soft tissue anomalies. It also grades osteoarthritis severity, enabling timely, personalized treatment. Study Design: The research used 1.3 million knee X-rays from a multi-site Indian clinical trial across government, private, and SME hospitals. The dataset ensured diversity in demographics, imaging equipment, and clinical settings. Rigorous annotation and preprocessing yielded high-quality training datasets for pathology-specific models like ResNet15 for joint space narrowing and DenseNet for osteoarthritis grading. Performance: The AI system achieved strong diagnostic accuracy across diverse imaging environments. Pathology-specific models excelled in precision, recall, and NPV, validated using Mean Squared Error (MSE), Intersection over Union (IoU), and Dice coefficient. Subgroup analyses across age, gender, and manufacturer variations confirmed generalizability for real-world applications. Conclusion: This scalable, cost-effective solution for bone health diagnostics demonstrated robust performance in a multi-site trial. It holds promise for widespread adoption, especially in resource-limited healthcare settings, transforming bone health management and enabling proactive patient care.
机构、总结、中文摘要均由AI分析而来，可能存在错误，请以论文正文为准。
